Concepedia

Erica Brivio

EB

Statistics

Publications

13

Citations

455

H-Index

12

Active since

2013

Affiliations

Princess Máxima Center(Current)

University of Milano-Bicocca

Erasmus MC - Sophia Children’s Hospital

Bambino Gesù Children's Hospital

Pfizer (United States)

Erica Brivio is an author at Princess Máxima Center specializing in medicine, pediatric oncology, and acute lymphoblastic leukemia therapy.

ORCID

Publications per year

2013–2024

13

Publications

13

A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)

Erica Brivio, Franco Locatelli, Marta López‐Yurda et al. · Blood · 2020 · 90 citations · Full text

, , +17

Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial

Edoardo Pennesi, Naomi Michels, Erica Brivio et al. · Leukemia · 2022 · 82 citations · Full text

, , +17

Treatment of childhood acute lymphoblastic leukemia in central America: A lower‐middle income countries experience

Marta Navarrete, Emanuela Rossi, Erica Brivio et al. · Pediatric Blood & Cancer · 2013 · 64 citations

, , +16

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents

Andrew D.J. Pearson, C. Michel Zwaan, E. Anders Kolb et al. · European Journal of Cancer · 2020 · 43 citations · Full text

, , +16

ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects

Erica Brivio, C. Michel Zwaan · Pediatric Blood & Cancer · 2019 · 39 citations · Full text

, , +14

1–5 of 13